What anxiety medications are safe for breastfeeding mothers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Anxiety Medications for Breastfeeding Mothers

Sertraline and paroxetine are the safest first-line anxiety medications for breastfeeding mothers due to their minimal transfer into breast milk and low risk of adverse effects in infants. 1, 2, 3

First-Line Options

  • Sertraline (Zoloft) is considered one of the safest antidepressants during breastfeeding with very low infant plasma concentrations and minimal reported adverse effects 1, 2
  • Paroxetine has similarly low infant exposure through breast milk and is recommended as a first-line agent for breastfeeding mothers 2, 3
  • Both medications should be started at low doses and titrated slowly while monitoring the infant for any adverse effects such as irritability, poor feeding, or sleep disturbances 1

Second-Line Options (Use with Caution)

  • Citalopram and fluoxetine have higher transfer rates into breast milk compared to sertraline and paroxetine, resulting in higher infant plasma levels 2, 4, 3
  • These medications should be used with caution and careful infant monitoring, though they can still be considered if the mother was already taking them during pregnancy 2
  • Venlafaxine also requires careful monitoring due to potentially higher infant exposure 2

Benzodiazepines in Breastfeeding

  • Short-acting benzodiazepines like lorazepam and midazolam may be used for short-term anxiety management 5
  • Midazolam has extensive first-pass metabolism resulting in low systemic bioavailability, making it relatively safer for occasional use 5
  • Diazepam should be avoided for regular use as it has an active metabolite (desmethyl-diazepam) with a prolonged half-life and transfers significantly into breast milk 5
  • The FDA label for lorazepam specifically states: "Lorazepam should not be administered to breast-feeding women, unless the expected benefit to the woman outweighs the potential risk to the infant" 6

Practical Recommendations

  • When initiating treatment:

    • Start with low doses and increase gradually 1, 2
    • Monitor the infant for unusual drowsiness, poor feeding, or irritability 1
    • Use the lowest effective dose to minimize infant exposure 1
  • To reduce infant exposure:

    • Consider timing breastfeeding to avoid peak medication concentrations in milk when possible 1
    • For mothers already on effective treatment during pregnancy, continuing the same medication is often preferable to switching 1, 2

Important Considerations and Monitoring

  • Premature infants or those with low birth weight may be more susceptible to medication effects and require closer monitoring 1
  • The benefits of treating maternal anxiety often outweigh the minimal risks to the breastfed infant 2, 7
  • Untreated maternal anxiety can negatively impact infant development and mother-infant bonding 7
  • Individual risk-benefit assessment should be performed for each mother-infant pair 2

Common Pitfalls to Avoid

  • Discontinuing necessary medication due to unfounded fears about breastfeeding safety 2, 7
  • Using medications with longer half-lives (like fluoxetine) as first-line agents in breastfeeding mothers 4, 3
  • Failing to monitor the infant for potential adverse effects, especially when using medications with higher transfer rates 1
  • Not considering the mother's previous medication response when selecting treatment 1, 2

References

Research

Antidepressant Use During Breastfeeding.

Current women's health reviews, 2011

Research

[The transfer of selective serotonin reuptake inhibitors to human milk].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.